logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
10/03/2026
Kumsin Biotech: The market application for the 12 indications of Trastuzumab Injection for tumor treatment has been accepted for review.
Latest
6 m ago
The South Korean composite stock price index rose by 6%, to 5568.56.
8 m ago
Shenzhen Stock Exchange: The list of securities included in the Hong Kong Stock Connect program will be adjusted, with MEGVII Technology being added. The adjustment will take effect on March 10th.
10 m ago
Satellite chemistry: Various products have adjusted prices in line with the market.
11 m ago
Japanese government bonds rise, following the trend of U.S. government bonds.
11 m ago
Brent crude fell 9% intraday, now trading at $89.92 per barrel.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.